Enamelate
Smart minerals. Stronger teeth.
BiPhasic-ACP™ technology for rapid, natural tooth remineralization.
BiPhasic-ACP™ technology for rapid, natural tooth remineralization.
Dental caries affect nearly half the global population, creating a $544 billion annual economic burden. In Canada alone, 96% of adults have experienced tooth decay.
Traditional dentistry is reactive, drilling and filling after damage becomes irreversible. But there's a better way...
Many people don't know that teeth can heal themselves. Acid damage and early-stage cavities are reversible through the natural process of remineralization, where trace levels of minerals dissolved in saliva can rebuild the first signs of damaged tooth enamel.
But nature needs help. Natural enamel remineralization is significantly limited by the low-levels of bioactive minerals in saliva. Current remineralization products are either too slow, contain concerning ingredients, or become ineffective before they reach your teeth.
BiPhasic-ACP™ delivers demonstrated performance across all metrics, with rapid remineralization in 6 x 1 hr applications (or less) and superior performance to top competitors studied under the same conditions. In direct comparative testing against leading casein-based ACP formulations, BiPhasic-ACP™ demonstrated superior remineralization capacity while eliminating common allergen concerns and formulation instability. Results validated through comprehensive in vitro analysis including SEM surface morphology, EDS chemical characterization, and ongoing microindentation hardness testing.
Enamel remineralized by BiPhasic-ACP™ shows near-complete restoration of acid-damaged enamel structure in 6 x 1 hr applications (or less).
We partner with established oral care brands and dental professionals to bring BiPhasic-ACP™ to market through a licensing model.
This approach allows us to scale rapidly while focusing on what we do best: advancing remineralization science.
BiPhasic-ACP™ qualifies for Natural Health Product (NHP) licensing in Canada, offering licensing partners a faster, more cost-effective path to market compared to prescription drug approval. NHP status enables distribution through mass-market retail channels while maintaining regulatory credibility.
Founder, President & Lead Scientist
Dr. Pietak brings over a decade of specialized expertise in calcium phosphate biomaterials to Enamelate. With a PhD focused on these materials and extensive experience in both academic and corporate research settings, she is a published expert in biomineralization and calcium phosphate biomaterials.
Her deep understanding of how minerals interact with biological systems led to the breakthrough innovations behind BiPhasic-ACP™. Dr. Pietak's vision is to make rapid, safe, natural tooth remineralization accessible to millions worldwide.
Interested in investment opportunities, sales, licensing, or research collaborations? We'd love to hear from you.